Aggiornamento in tema di trattamento della COPD

Translated title of the contribution: Updates in the treatment of COPD

S. Zaccaria, C. F. Donner

Research output: Contribution to journalArticle

Abstract

Treatment of chronic obstructive pulmonary disease (COPD) is currently multidisciplinary. Available options include the use of topical anticholinergic drugs, which is now a standard of cure for COPD, obviously along with prevention from environmental factors, chest physiotherapy and traditional respiratory treatment (oxygen, ventilation) when needed. Frequently presenting manifestations outcome is dramatic, appearing in a state of so far apparently normal life; in that case treatment must be complex and aggressive from the beginning, possibly with immediate referral for surgical intervention. Broad and standardized use of topical bronchodilators has modified the standard care for COPD. In particular, anticholinergic drugs, both available (ipratropium) or to come (tiotropium) proved simple to use, efficient and very well tolerated. Anticholinergic drugs have been reported superior to the widely tested beta-agonists. Surgical treatment is more complex. Single lung transplant, bilateral lung transplant and lung volume reduction (both as bullaectomy or as regional emphysema resection) are the available surgical options. Major failure risk arise from unaccurate patients selection, and this is true for lung resetion as well as for lung transplant, although indications to lung trasplant are less strict. Both lung volume reduction and lung transplant currently show encouraging and improving results, thank to advances in anestesia procedures and in post-surgical care protocols, not to mention the increasing experience of surgical Centers.

Original languageItalian
Pages (from-to)181-187
Number of pages7
JournalGaslini
Volume33
Issue number2
Publication statusPublished - 2001

Fingerprint

Chronic Obstructive Pulmonary Disease
Lung
Cholinergic Antagonists
Transplants
Pneumonectomy
Pharmaceutical Preparations
Ipratropium
Bronchodilator Agents
Emphysema
Patient Selection
Ventilation
Thorax
Referral and Consultation
Oxygen

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Zaccaria, S., & Donner, C. F. (2001). Aggiornamento in tema di trattamento della COPD. Gaslini, 33(2), 181-187.

Aggiornamento in tema di trattamento della COPD. / Zaccaria, S.; Donner, C. F.

In: Gaslini, Vol. 33, No. 2, 2001, p. 181-187.

Research output: Contribution to journalArticle

Zaccaria, S & Donner, CF 2001, 'Aggiornamento in tema di trattamento della COPD', Gaslini, vol. 33, no. 2, pp. 181-187.
Zaccaria, S. ; Donner, C. F. / Aggiornamento in tema di trattamento della COPD. In: Gaslini. 2001 ; Vol. 33, No. 2. pp. 181-187.
@article{c0856191516d4d698b0271616b645ecd,
title = "Aggiornamento in tema di trattamento della COPD",
abstract = "Treatment of chronic obstructive pulmonary disease (COPD) is currently multidisciplinary. Available options include the use of topical anticholinergic drugs, which is now a standard of cure for COPD, obviously along with prevention from environmental factors, chest physiotherapy and traditional respiratory treatment (oxygen, ventilation) when needed. Frequently presenting manifestations outcome is dramatic, appearing in a state of so far apparently normal life; in that case treatment must be complex and aggressive from the beginning, possibly with immediate referral for surgical intervention. Broad and standardized use of topical bronchodilators has modified the standard care for COPD. In particular, anticholinergic drugs, both available (ipratropium) or to come (tiotropium) proved simple to use, efficient and very well tolerated. Anticholinergic drugs have been reported superior to the widely tested beta-agonists. Surgical treatment is more complex. Single lung transplant, bilateral lung transplant and lung volume reduction (both as bullaectomy or as regional emphysema resection) are the available surgical options. Major failure risk arise from unaccurate patients selection, and this is true for lung resetion as well as for lung transplant, although indications to lung trasplant are less strict. Both lung volume reduction and lung transplant currently show encouraging and improving results, thank to advances in anestesia procedures and in post-surgical care protocols, not to mention the increasing experience of surgical Centers.",
keywords = "Bronchodilators, Bullaectomy, Chronic obstructive pulmonary disease, Lung inflammation, Lung transplant, Treatment",
author = "S. Zaccaria and Donner, {C. F.}",
year = "2001",
language = "Italian",
volume = "33",
pages = "181--187",
journal = "Gaslini",
issn = "0390-5845",
publisher = "Masson SpA",
number = "2",

}

TY - JOUR

T1 - Aggiornamento in tema di trattamento della COPD

AU - Zaccaria, S.

AU - Donner, C. F.

PY - 2001

Y1 - 2001

N2 - Treatment of chronic obstructive pulmonary disease (COPD) is currently multidisciplinary. Available options include the use of topical anticholinergic drugs, which is now a standard of cure for COPD, obviously along with prevention from environmental factors, chest physiotherapy and traditional respiratory treatment (oxygen, ventilation) when needed. Frequently presenting manifestations outcome is dramatic, appearing in a state of so far apparently normal life; in that case treatment must be complex and aggressive from the beginning, possibly with immediate referral for surgical intervention. Broad and standardized use of topical bronchodilators has modified the standard care for COPD. In particular, anticholinergic drugs, both available (ipratropium) or to come (tiotropium) proved simple to use, efficient and very well tolerated. Anticholinergic drugs have been reported superior to the widely tested beta-agonists. Surgical treatment is more complex. Single lung transplant, bilateral lung transplant and lung volume reduction (both as bullaectomy or as regional emphysema resection) are the available surgical options. Major failure risk arise from unaccurate patients selection, and this is true for lung resetion as well as for lung transplant, although indications to lung trasplant are less strict. Both lung volume reduction and lung transplant currently show encouraging and improving results, thank to advances in anestesia procedures and in post-surgical care protocols, not to mention the increasing experience of surgical Centers.

AB - Treatment of chronic obstructive pulmonary disease (COPD) is currently multidisciplinary. Available options include the use of topical anticholinergic drugs, which is now a standard of cure for COPD, obviously along with prevention from environmental factors, chest physiotherapy and traditional respiratory treatment (oxygen, ventilation) when needed. Frequently presenting manifestations outcome is dramatic, appearing in a state of so far apparently normal life; in that case treatment must be complex and aggressive from the beginning, possibly with immediate referral for surgical intervention. Broad and standardized use of topical bronchodilators has modified the standard care for COPD. In particular, anticholinergic drugs, both available (ipratropium) or to come (tiotropium) proved simple to use, efficient and very well tolerated. Anticholinergic drugs have been reported superior to the widely tested beta-agonists. Surgical treatment is more complex. Single lung transplant, bilateral lung transplant and lung volume reduction (both as bullaectomy or as regional emphysema resection) are the available surgical options. Major failure risk arise from unaccurate patients selection, and this is true for lung resetion as well as for lung transplant, although indications to lung trasplant are less strict. Both lung volume reduction and lung transplant currently show encouraging and improving results, thank to advances in anestesia procedures and in post-surgical care protocols, not to mention the increasing experience of surgical Centers.

KW - Bronchodilators

KW - Bullaectomy

KW - Chronic obstructive pulmonary disease

KW - Lung inflammation

KW - Lung transplant

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0034760023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034760023&partnerID=8YFLogxK

M3 - Articolo

VL - 33

SP - 181

EP - 187

JO - Gaslini

JF - Gaslini

SN - 0390-5845

IS - 2

ER -